Prevalence of UGT1A1*28 promoter polymorphism in the omani population: Implications for irinotecan treatment in GI cancer

被引：0
|
作者：
Al Ghoche, A. A. G. [1 ]
Al Zadjali, S. [2 ]
Pullanhi, A. [3 ]
Alfahdi, A. [3 ]
Al-Balushi, A. [2 ]
Al-Mahrouqi, N. [2 ]
Abu Omar, R. [3 ]
Salman, B. [4 ]
Almoundhri, M. [1 ]
机构：
[1] SQCCCRC Sultan Qaboos Comprehens Canc Care & Res, Oncol Dept, Muscat, Oman
[2] SQCCCRC Sultan Qaboos Comprehens Canc Care & Res, Res Labs, Muscat, Oman
[3] Sultan Qaboos Univ Hosp, Muscat, Oman
[4] SQCCCRC Sultan Qaboos Comprehens Canc Care & Res, Pharm Dept, Muscat, Oman
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
525P
引用
收藏
页码：S208 / S209
页数：2
相关论文
共 50 条
  • [41] Comparison of effects of UGT1A1*6 and UGT1A1*28 on irinotecan-induced adverse reactions in the Japanese population: analysis of the Biobank Japan Project
    Keiko Hikino
    Takeshi Ozeki
    Masaru Koido
    Chikashi Terao
    Yoichiro Kamatani
    Yoshinori Murakami
    Michiaki Kubo
    Taisei Mushiroda
    Journal of Human Genetics, 2019, 64 : 1195 - 1202
  • [42] UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer
    E Marcuello
    A Altés
    A Menoyo
    E del Rio
    M Gómez-Pardo
    M Baiget
    British Journal of Cancer, 2004, 91 : 678 - 682
  • [43] Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population
    Nishikawa, Yoshitaka
    Kanai, Masashi
    Narahara, Maiko
    Tamon, Akiko
    Brown, J. B.
    Taneishi, Kei
    Nakatsui, Masahiko
    Okamoto, Kazuya
    Uneno, Yu
    Yamaguchi, Daisuke
    Tomono, Teruko
    Mori, Yukiko
    Matsumoto, Shigemi
    Okuno, Yasushi
    Muto, Manabu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (02) : 269 - 273
  • [44] Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population
    Yoshitaka Nishikawa
    Masashi Kanai
    Maiko Narahara
    Akiko Tamon
    J. B. Brown
    Kei Taneishi
    Masahiko Nakatsui
    Kazuya Okamoto
    Yu Uneno
    Daisuke Yamaguchi
    Teruko Tomono
    Yukiko Mori
    Shigemi Matsumoto
    Yasushi Okuno
    Manabu Muto
    International Journal of Clinical Oncology, 2017, 22 : 269 - 273
  • [45] UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer
    Marcuello, E
    Altés, A
    Menoyo, A
    del Rio, E
    Gómez-Pardo, M
    Baiget, M
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 678 - 682
  • [46] Frequency of UGT1A1*28 gene polymorphism in Chinese gastrointestinal cancer patients and its relationship with irinotecan-related diarrhea
    Su, Y.
    Ma, T.
    Ye, Z. B.
    Zhang, J.
    Zhu, Z. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [47] Heterozygosity for a polymorphism in the promoter region of the UGT1A1 gene - Reply
    Strassburg, CP
    Manns, MP
    JOURNAL OF HEPATOLOGY, 2001, 35 (01) : 149 - 150
  • [48] Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism
    Berardi, Alberto
    Lugli, Licia
    Ferrari, Fabrizio
    Gargano, Giancarlo
    D'Apolito, Maria
    Marrone, Agnese
    Iolascon, Achille
    BIOLOGY OF THE NEONATE, 2006, 90 (04): : 243 - 246
  • [49] Effects of UGT1A1*28 polymorphism on raloxifene pharmacokinetics and pharmacodynamics
    Trontelj, Jurij
    Marc, Janja
    Zavratnik, Andrej
    Bogataj, Marija
    Mrhar, Ales
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (04) : 437 - 444
  • [50] Clinical Implications of UGT1A1*28 Genotype Testing in Colorectal Cancer Patients
    Shulman, Katerina
    Cohen, Ilana
    Barnett-Griness, Ofra
    Kuten, Abraham
    Gruber, Stephen B.
    Lejbkowicz, Flavio
    Rennert, Gad
    CANCER, 2011, 117 (14) : 3156 - 3162
12345